Page last updated: 2024-12-04

bisbenzimidazole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID2392
CHEMBL ID301735
CHEBI ID52082
SCHEMBL ID74554
SCHEMBL ID5332220
SCHEMBL ID13856958
SCHEMBL ID18089342
MeSH IDM0515726

Synonyms (77)

Synonym
LS-15104
NCI60_002801
hoechst 33258
p-(5-(5-(4-methylpiperazin-1-yl)benzimidazol-2-yl)benzimidazol-2-yl)phenol
hoe-33258
p-(5-(5-(4-methyl-1-piperazinyl)-2-benzimidazolyl)-2-benzimidazolyl)phenol
phenol, p-(5-(5-(4-methyl-1-piperazinyl)-2-benzimidazolyl)-2-benzimidazolyl)-
phenol, 4-(5-(4-methyl-1-piperazinyl)(2,5'-bi-1h-benzimidazol)-2'-yl)-
4-(5-(4-methyl-1-piperazinyl)(2,5'-bi-1h-benzimidazol)-2'-yl)phenol
einecs 245-689-0
nsc-322921
nsc322921 ,
bisbenzimidazole
hoe 33258 (trihydrochloride)
pibenzimol
hoechst 33258 (trihydrochloride)
4-[5-[5-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-benzimidazol-2-yl]phenol
phenol, 4-[5-(4-methyl-1-piperazinyl)[2,5'-bi-1h-benzimidazol]-2'-yl]-
23491-44-3
bisbenzimide (trihydrochloride)
p-(5-(5-(4-methyl-1-piperazinyl)-1h-2-benzimidazolyl)-1h-2-benzimidazolyl)phenol
NCGC00014751
2'-(4-hydroxyphenyl)-5-(4-methyl-1-piperazinyl)-2,5'-bi-benzimidazole
NCI322921
KBIOSS_002449
KBIO2_007579
KBIO2_005011
KBIO3_002921
KBIOGR_002443
KBIO2_002443
NCISTRUC1_000146
NCISTRUC2_001668
CMAP_000054
NCGC00097852-01
CHEBI:52082 ,
4-[5-(4-methylpiperazin-1-yl)-1h,1'h-2,5'-bibenzimidazol-2'-yl]phenol
CHEMBL301735
CCG-37532
NCGC00014751-02
nsc 322921
lhq7j5kv9b ,
unii-lhq7j5kv9b
ccris 8389
HY-15558
CS-1301
FT-0638328
sl-1063
2-(2-(4-hydroxyphenyl)-6-benzimidazolyl)-6-(1-methyl-4-piperazinyl)benzimidazole
sl-11063
bisbenzimide [mi]
2-(2-(4-hydroxyphenyl)-6-benzimidazolyl)-6-(1-methyl-4-piperazyl)benzimidazole
SCHEMBL74554
SCHEMBL5332220
DTXSID3066899
SCHEMBL13856958
AKOS024285175
2-[2-(4-hydroxyphenyl)-6-benzimidazolyl]-6-(1-methyl-4-piperazyl)benzimidazole
bisbenzimidazole trihydrochloride (salt/mix)
phenol, p-[5-[5-(4-methyl-1-piperazinyl)-2-benzimidazolyl]-2-benzimidazolyl]-
bisbenzimide (salt/mix)
pibenzimol hcl (salt/mix)
bis-benzimide
phenol,4-[5-(4-methyl-1-piperazinyl)[2,5'-bi-1h-benzimidazol]-2'-yl]-
SCHEMBL18089342
2'-(4-hydroxyphenyl)-5-(4-methyl-1-piperazinyl)-2,5'-bi-1h-benzimidazole
hoechst33258
4-(5-(4-methylpiperazin-1-yl)-1h,1'h-[2,5'-bibenzo[d]imidazol]-2'-yl)phenol
4-[6-(4-methylpiperazin-1-yl)-1h,3'h-2,5'-bibenzimidazol-2'-yl]phenol
ADHLSOGCYJHJBG-UHFFFAOYSA-N
4-(5-(4-methylpiperazin-1-yl)-1h,1'h-2,5'-bibenzo[d]imidazol-2'-yl)phenol
Q27123162
bdbm50498270
bisbenzimide h 33258;h 33258
4-[6-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-benzimidazol-2-yl]phenol
para-(5-(5-(4-methyl-1-piperazinyl)-2-benzoimidazolyl)-2-benzoimidazolyl)phenol
F76803
PD118617

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Hoechst 33258 itself was selectively toxic for the MM96E melanoma cell line compared with other cell lines, induced a highly dendritic morphology, increased tyrosinase activity and tyrosinase mRNA but decreased the level of gp75 (TRP-1) mRNA; message for a third pigment gene, Pmel-17, was unchanged."( Transcriptional regulation of differentiation, selective toxicity and ATGCAAAT binding of bisbenzimidazole derivatives in human melanoma cells.
Danoy, PA; Dong, Y; Dunn, IS; Jacobs, JJ; Kaushal, A; McGregor, K; Michel, J; Sturm, RA; Wong, SS; Zhang, XM, 1994
)
0.51
" Distamycin A readily inhibited nucleic acid and protein synthesis and was more toxic to the ring stage than to the trophozoite stage in various parasite strains, irrespective of their susceptibility to chloroquine."( Selective toxicity to malaria parasites by non-intercalating DNA-binding ligands.
Ginsburg, H; Krugliak, M; Nissani, E; Williamson, DH, 1993
)
0.29
" Salvianic acid A (SA), isolated from the Chinese herbal medicine Salvia miltiorrhiza, is capable of protecting diverse kinds of cells from damage caused by a variety of toxic stimuli."( Salvianic acid A protects human neuroblastoma SH-SY5Y cells against MPP+-induced cytotoxicity.
Wang, XJ; Xu, JX, 2005
)
0.33
"The hippocampus is extremely sensitive to microenvironmental signals and toxic events, including massive glutamate release."( Role of c-Fos protein on glutamate toxicity in primary neural hippocampal cells.
Antonelli, T; Calzà, L; Fernandez, M; Ferraro, L; Giardino, L; Pirondi, S, 2005
)
0.33
" In the present study, we treated human normal liver L-02 cells (L-02 cells) with triptolide in vitro and investigated its toxic effects."( Involvement of mitochondrial pathway in triptolide-induced cytotoxicity in human normal liver L-02 cells.
Duan, W; He, L; Hu, L; Huang, J; Jiang, Z; Li, F; Liu, C; Shu, B; Xiao, Y; Yao, J; Zhang, L, 2008
)
0.35
" Recent studies showed that puerarin protects different cell types from damage caused by a variety of toxic stimuli."( Protective effect of Puerarin on β-amyloid-induced neurotoxicity in rat hippocampal neurons.
Cai, F; Lin, F; Wu, G; Xie, B, 2012
)
0.38
" In the 0-60 microM concentration range, only the DB(11) displayed a significant toxic effect on the normal cells, whereas the effect of DB(n) investigated on the cancer cells was not significant."( [Dimeric bisberzimidazoles: cytotoxicity and effects on DNA methylation in normal and cancer human cells].
Dariĭ, MV; Gromova, ES; Ivanov, AA; Kostiuk, SV; Rakhimova, AR; Tashlitskiĭ, VN; Veĭko, NN; Zhuze, AL,
)
0.13
"There is an urgent need to make cisplatin (cDDP) more effective and less toxic in the treatment of ovarian cancer for its systemic side effects and high resistance rate."( Quercetin induces endoplasmic reticulum stress to enhance cDDP cytotoxicity in ovarian cancer: involvement of STAT3 signaling.
Chen, G; Gao, Q; Gong, C; Liao, J; Liu, Y; Ma, D; Sun, C; Wei, X; Yang, Z; Zhang, T; Zhou, X, 2015
)
0.42
" Single bolus dose and 28-days of repeated administration of DMA in mice for toxicity studies determined an LD50 of >2000 mg/kg body weight (bw) and 225 mg/kg bw, respectively, suggesting DMA is safe."( Preclinical Evaluation of DMA, a Bisbenzimidazole, as Radioprotector: Toxicity, Pharmacokinetics, and Biodistribution Studies in Balb/c Mice.
Aneja, R; Chuttani, K; Gundala, SR; Hazari, PP; Katyal, A; Lal, J; Mishra, AK; Nimesh, H; Sharma, A; Tandon, V; Tiwari, V; Yang, C, 2015
)
0.7

Compound-Compound Interactions

ExcerptReferenceRelevance
" We carried out the in vitro study using selective COX-2 inhibitor celecoxib combined with EGFR-tyrosine kinase inhibitor (EGFR-TKI) ZD1839 on NSCLC cell lines to investigate the anti proliferation effect and the cell molecular mechanism."( Selective COX-2 inhibitor celecoxib combined with EGFR-TKI ZD1839 on non-small cell lung cancer cell lines: in vitro toxicity and mechanism study.
Chen, L; He, Y; Huang, H; Liao, H; Wei, W, 2008
)
0.35

Dosage Studied

ExcerptRelevanceReference
" In this manner, complete dose-response curves could be obtained from one plate."( Rapid fluorescence-based assay for radiosensitivity and chemosensitivity testing in mammalian cells in vitro.
Begg, AC; Mooren, E, 1989
)
0.28
" Comparison to chromosome-aberration studies demonstrates the suitability of this method to screen quickly for adequate dosing of a cytotoxic substance and also gives information on the appropriate preparation interval."( Flow-cytometric cell-cycle analysis of Chinese hamster cells following exposure to cytotoxicants.
Fertig, G; Miltenburger, HG, 1989
)
0.28
" The results of gene dosage studies using (1) a histochemical stain to measure X-linked glucose-6-phosphate dehydrogenase (G6PD) activity in single cells and (2) cellulose acetate electrophoresis of G6PD activity in cell extracts also indicated that both Xs in these strains were genetically active."( Human X chromosomes: synchrony of DNA replication in diploid and triploid fibroblasts with multiple active or inactive X chromosomes.
Breg, WR; Willard, HF, 1980
)
0.26
" The results of each culture are presented as a drug dose-response curve."( Computer software for testing drug susceptibility of malaria parasites.
Janse, CJ; Reinders, PP; Tanke, HJ; van der Keur, M; van Engen, A; van Vianen, PH, 1995
)
0.29
" After investigation of their dose-response behaviors and structure-activity relationships, chlorogenic acids and flavonoid glycosides were found to be DNA-binders via both minor groove-binding and intercalation modes."( An analysis method for simultaneous screening of deoxyribonucleic acid-binding active compounds and investigating their mechanisms by ultra-fast liquid chromatography tandem mass spectrometry coupled with fluorescence detection technology.
Chen, S; Lin, Z; Ren, B; Tong, L; Wang, H; Zhang, C, 2015
)
0.42
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
fluorochromeA fluorescent dye used to stain biological specimens.
anthelminthic drugSubstance intended to kill parasitic worms (helminths).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
bibenzimidazole
N-methylpiperazine
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (12)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, HADH2 proteinHomo sapiens (human)Potency3.16230.025120.237639.8107AID893
Chain B, HADH2 proteinHomo sapiens (human)Potency3.16230.025120.237639.8107AID893
LuciferasePhotinus pyralis (common eastern firefly)Potency3.98110.007215.758889.3584AID411
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency7.07950.011212.4002100.0000AID1030
nonstructural protein 1Influenza A virus (A/WSN/1933(H1N1))Potency1.12200.28189.721235.4813AID2326
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1Homo sapiens (human)Potency3.16230.001815.663839.8107AID894
survival motor neuron protein isoform dHomo sapiens (human)Potency4.46680.125912.234435.4813AID1458
Polyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)Potency3.98110.316212.765731.6228AID881
Histamine H2 receptorCavia porcellus (domestic guinea pig)Potency3.98110.00638.235039.8107AID881
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
DNA topoisomerase 1Homo sapiens (human)IC50 (µMol)22.86000.02101.862610.0000AID1227434
DNA topoisomerase 2-alphaHomo sapiens (human)IC50 (µMol)28.92000.48004.35649.9400AID1227435
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
DNA topoisomerase 2-betaHomo sapiens (human)Ka0.26400.26400.27400.2840AID57051
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (53)

Processvia Protein(s)Taxonomy
lipid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
phospholipid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
apoptotic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell population proliferationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of macrophage derived foam cell differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonic acid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell migrationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
prostate gland developmentPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
regulation of epithelial cell differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of chemokine productionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of peroxisome proliferator activated receptor signaling pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of keratinocyte differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell cyclePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of growthPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
hepoxilin biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
endocannabinoid signaling pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cannabinoid biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipoxin A4 biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleic acid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipid oxidationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipoxygenase pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
DNA topological changeDNA topoisomerase 1Homo sapiens (human)
chromatin remodelingDNA topoisomerase 1Homo sapiens (human)
circadian rhythmDNA topoisomerase 1Homo sapiens (human)
response to xenobiotic stimulusDNA topoisomerase 1Homo sapiens (human)
programmed cell deathDNA topoisomerase 1Homo sapiens (human)
phosphorylationDNA topoisomerase 1Homo sapiens (human)
peptidyl-serine phosphorylationDNA topoisomerase 1Homo sapiens (human)
circadian regulation of gene expressionDNA topoisomerase 1Homo sapiens (human)
embryonic cleavageDNA topoisomerase 1Homo sapiens (human)
chromosome segregationDNA topoisomerase 1Homo sapiens (human)
DNA replicationDNA topoisomerase 1Homo sapiens (human)
hematopoietic progenitor cell differentiationDNA topoisomerase 2-alphaHomo sapiens (human)
DNA topological changeDNA topoisomerase 2-alphaHomo sapiens (human)
DNA ligationDNA topoisomerase 2-alphaHomo sapiens (human)
DNA damage responseDNA topoisomerase 2-alphaHomo sapiens (human)
chromosome segregationDNA topoisomerase 2-alphaHomo sapiens (human)
female meiotic nuclear divisionDNA topoisomerase 2-alphaHomo sapiens (human)
apoptotic chromosome condensationDNA topoisomerase 2-alphaHomo sapiens (human)
embryonic cleavageDNA topoisomerase 2-alphaHomo sapiens (human)
regulation of circadian rhythmDNA topoisomerase 2-alphaHomo sapiens (human)
positive regulation of apoptotic processDNA topoisomerase 2-alphaHomo sapiens (human)
positive regulation of single stranded viral RNA replication via double stranded DNA intermediateDNA topoisomerase 2-alphaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIDNA topoisomerase 2-alphaHomo sapiens (human)
rhythmic processDNA topoisomerase 2-alphaHomo sapiens (human)
negative regulation of DNA duplex unwindingDNA topoisomerase 2-alphaHomo sapiens (human)
resolution of meiotic recombination intermediatesDNA topoisomerase 2-alphaHomo sapiens (human)
sister chromatid segregationDNA topoisomerase 2-alphaHomo sapiens (human)
neuron migrationDNA topoisomerase 2-betaHomo sapiens (human)
DNA topological changeDNA topoisomerase 2-betaHomo sapiens (human)
axonogenesisDNA topoisomerase 2-betaHomo sapiens (human)
B cell differentiationDNA topoisomerase 2-betaHomo sapiens (human)
forebrain developmentDNA topoisomerase 2-betaHomo sapiens (human)
positive regulation of single stranded viral RNA replication via double stranded DNA intermediateDNA topoisomerase 2-betaHomo sapiens (human)
cellular response to hydrogen peroxideDNA topoisomerase 2-betaHomo sapiens (human)
cellular response to ATPDNA topoisomerase 2-betaHomo sapiens (human)
cellular senescenceDNA topoisomerase 2-betaHomo sapiens (human)
positive regulation of double-strand break repair via nonhomologous end joiningDNA topoisomerase 2-betaHomo sapiens (human)
sister chromatid segregationDNA topoisomerase 2-betaHomo sapiens (human)
resolution of meiotic recombination intermediatesDNA topoisomerase 2-betaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (29)

Processvia Protein(s)Taxonomy
iron ion bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
calcium ion bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
protein bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipid bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleate 13S-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonate 8(S)-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonate 15-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleate 9S-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingDNA topoisomerase 1Homo sapiens (human)
DNA bindingDNA topoisomerase 1Homo sapiens (human)
chromatin bindingDNA topoisomerase 1Homo sapiens (human)
double-stranded DNA bindingDNA topoisomerase 1Homo sapiens (human)
single-stranded DNA bindingDNA topoisomerase 1Homo sapiens (human)
RNA bindingDNA topoisomerase 1Homo sapiens (human)
DNA topoisomerase type I (single strand cut, ATP-independent) activityDNA topoisomerase 1Homo sapiens (human)
protein serine/threonine kinase activityDNA topoisomerase 1Homo sapiens (human)
protein bindingDNA topoisomerase 1Homo sapiens (human)
ATP bindingDNA topoisomerase 1Homo sapiens (human)
DNA binding, bendingDNA topoisomerase 1Homo sapiens (human)
protein domain specific bindingDNA topoisomerase 1Homo sapiens (human)
supercoiled DNA bindingDNA topoisomerase 1Homo sapiens (human)
magnesium ion bindingDNA topoisomerase 2-alphaHomo sapiens (human)
DNA bindingDNA topoisomerase 2-alphaHomo sapiens (human)
chromatin bindingDNA topoisomerase 2-alphaHomo sapiens (human)
RNA bindingDNA topoisomerase 2-alphaHomo sapiens (human)
DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activityDNA topoisomerase 2-alphaHomo sapiens (human)
protein kinase C bindingDNA topoisomerase 2-alphaHomo sapiens (human)
protein bindingDNA topoisomerase 2-alphaHomo sapiens (human)
ATP bindingDNA topoisomerase 2-alphaHomo sapiens (human)
ATP-dependent activity, acting on DNADNA topoisomerase 2-alphaHomo sapiens (human)
DNA binding, bendingDNA topoisomerase 2-alphaHomo sapiens (human)
protein homodimerization activityDNA topoisomerase 2-alphaHomo sapiens (human)
ubiquitin bindingDNA topoisomerase 2-alphaHomo sapiens (human)
protein heterodimerization activityDNA topoisomerase 2-alphaHomo sapiens (human)
DNA bindingDNA topoisomerase 2-betaHomo sapiens (human)
chromatin bindingDNA topoisomerase 2-betaHomo sapiens (human)
DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activityDNA topoisomerase 2-betaHomo sapiens (human)
protein bindingDNA topoisomerase 2-betaHomo sapiens (human)
ATP bindingDNA topoisomerase 2-betaHomo sapiens (human)
ribonucleoprotein complex bindingDNA topoisomerase 2-betaHomo sapiens (human)
metal ion bindingDNA topoisomerase 2-betaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (24)

Processvia Protein(s)Taxonomy
nucleusPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cytosolPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cytoskeletonPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
plasma membranePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
adherens junctionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
focal adhesionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
membranePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
extracellular exosomePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
nuclear chromosomeDNA topoisomerase 1Homo sapiens (human)
P-bodyDNA topoisomerase 1Homo sapiens (human)
fibrillar centerDNA topoisomerase 1Homo sapiens (human)
male germ cell nucleusDNA topoisomerase 1Homo sapiens (human)
nucleusDNA topoisomerase 1Homo sapiens (human)
nucleoplasmDNA topoisomerase 1Homo sapiens (human)
nucleolusDNA topoisomerase 1Homo sapiens (human)
perikaryonDNA topoisomerase 1Homo sapiens (human)
protein-DNA complexDNA topoisomerase 1Homo sapiens (human)
nucleolusDNA topoisomerase 1Homo sapiens (human)
nucleolusDNA topoisomerase 2-alphaHomo sapiens (human)
nuclear chromosomeDNA topoisomerase 2-alphaHomo sapiens (human)
centrioleDNA topoisomerase 2-alphaHomo sapiens (human)
chromosome, centromeric regionDNA topoisomerase 2-alphaHomo sapiens (human)
condensed chromosomeDNA topoisomerase 2-alphaHomo sapiens (human)
male germ cell nucleusDNA topoisomerase 2-alphaHomo sapiens (human)
nucleusDNA topoisomerase 2-alphaHomo sapiens (human)
nucleoplasmDNA topoisomerase 2-alphaHomo sapiens (human)
nucleolusDNA topoisomerase 2-alphaHomo sapiens (human)
cytoplasmDNA topoisomerase 2-alphaHomo sapiens (human)
DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complexDNA topoisomerase 2-alphaHomo sapiens (human)
protein-containing complexDNA topoisomerase 2-alphaHomo sapiens (human)
ribonucleoprotein complexDNA topoisomerase 2-alphaHomo sapiens (human)
nucleusDNA topoisomerase 2-alphaHomo sapiens (human)
nucleolusDNA topoisomerase 2-betaHomo sapiens (human)
heterochromatinDNA topoisomerase 2-betaHomo sapiens (human)
nucleusDNA topoisomerase 2-betaHomo sapiens (human)
nucleoplasmDNA topoisomerase 2-betaHomo sapiens (human)
nucleolusDNA topoisomerase 2-betaHomo sapiens (human)
cytosolDNA topoisomerase 2-betaHomo sapiens (human)
ribonucleoprotein complexDNA topoisomerase 2-betaHomo sapiens (human)
nucleusDNA topoisomerase 2-betaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (166)

Assay IDTitleYearJournalArticle
AID569116Induction of cell cycle arrest in human HeLa assessed as accumulation at G0/G1-phase at 5x10'-5 M after 48 hrs by FACS analysis (RVb = 62.2+/-4.4%)2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis, DNA/RNA affinity and antitumour activity of new aromatic diamidines linked by 3,4-ethylenedioxythiophene.
AID536181Cytotoxicity against human TK10 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID536058Inhibition of EGF-induced MEK5 activity in HEK293 cells assessed as phosphorylated ERK5 level at 10 uM after 1 hr by Western blotting relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID9817Antitumor activity of compound for 96-h exposure in A2780 human ovarian cell line2001Journal of medicinal chemistry, Jan-18, Volume: 44, Issue:2
A new class of symmetric bisbenzimidazole-based DNA minor groove-binding agents showing antitumor activity.
AID569117Induction of cell cycle arrest in human HeLa assessed as accumulation at G0/G1-phase at 5x10'-5 M after 72 hrs by FACS analysis (RVb = 62.2+/-4.4%)2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis, DNA/RNA affinity and antitumour activity of new aromatic diamidines linked by 3,4-ethylenedioxythiophene.
AID536155Cytotoxicity against human SF539 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID536169Cytotoxicity against human OVCAR-3 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID304719Binding affinity to calf thymus dodecamer DNA assessed as thermal stability in cacodylate buffer containing 0.1 M NaCl at 12 uM2007Journal of medicinal chemistry, Dec-27, Volume: 50, Issue:26
Amine-guanidine switch: a promising approach to improve DNA binding and antiproliferative activities.
AID536168Cytotoxicity against human IGROV1 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID536059Cytotoxicity against human CCRF-CEM cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID57391DNA binding activity as denaturation temperature on GC to poly (dGC)-poly(dGC) normalized to ethidium bromide1992Journal of medicinal chemistry, Feb-07, Volume: 35, Issue:3
Structure and DNA binding activity of analogues of 1,5-bis(4-amidinophenoxy)pentane (pentamidine)
AID536061Cytotoxicity against human K562 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID536185Cytotoxicity against human MCF7 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID536166Cytotoxicity against human UACC257 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID536149Cytotoxicity against human HCT15 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID536072Cytotoxicity against human NCI-H460 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID1309052Antifungal activity against Candida albicans ATCC MYA-1003 after 48 hrs by CLSI M27-A3 method2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Synthesis and investigation of novel benzimidazole derivatives as antifungal agents.
AID477016Binding affinity to calf thymus DNA assessed as temperature required to cause 50% of DNA denatured at 10 uM by thermal denaturation assay2010European journal of medicinal chemistry, Apr, Volume: 45, Issue:4
Synthesis, cytotoxicity and DNA-binding of novel bisnaphthalimidopropyl derivatives in breast cancer MDA-MB-231 cells.
AID569089Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis, DNA/RNA affinity and antitumour activity of new aromatic diamidines linked by 3,4-ethylenedioxythiophene.
AID395133Binding affinity to poly(dA).poly(dT) duplex DNA assessed as ratio of KA to KB by ESI-MS analysis2008European journal of medicinal chemistry, Nov, Volume: 43, Issue:11
Ligand binding to nucleic acids and proteins: Does selectivity increase with strength?
AID1309057Antifungal activity against Aspergillus nidulans ATCC 38163 after 48 hrs by CLSI M38-A2 method2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Synthesis and investigation of novel benzimidazole derivatives as antifungal agents.
AID536069Cytotoxicity against human NCI-H226 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID1309053Antifungal activity against Candida glabrata ATCC 2001 after 48 hrs by CLSI M27-A3 method2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Synthesis and investigation of novel benzimidazole derivatives as antifungal agents.
AID1227443Antibacterial activity against Staphylococcus aureus ATCC 33591 after 24 hrs by microbroth dilution method2014MedChemComm, Jun-01, Volume: 5, Issue:6
Selective Inhibition of Bacterial Topoisomerase I by alkynyl-bisbenzimidazoles.
AID394430Cell cycle distribution in human HeLa cells assessed as accumulation at G0/G1 phase at 10 uM after 48 hrs by propidium iodide-based flow cytometry2009Bioorganic & medicinal chemistry, Mar-15, Volume: 17, Issue:6
Effect of 3,4-ethylenedioxy-extension of thiophene core on the DNA/RNA binding properties and biological activity of bisbenzimidazole amidines.
AID536178Cytotoxicity against human Caki1 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID536147Cytotoxicity against human HCC2998 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID536179Cytotoxicity against human RXF393 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID3218Kinetically Defined Association Constant for 28-mer AATT hairpin.2001Journal of medicinal chemistry, Aug-02, Volume: 44, Issue:16
Experimental precedent for the need to involve the primary hydration layer of DNA in lead drug design.
AID218907Association constant (Ka) with DNA dodecamer d(CCGGAATTCCGG) was determined1999Bioorganic & medicinal chemistry letters, Dec-06, Volume: 9, Issue:23
Synthesis of a fluorescent microgonotropen (FMGT-1) and its interactions with the dodecamer d(CCGGAATTCCGG).
AID536172Cytotoxicity against human OVCAR8 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID394434Cell cycle distribution in human HeLa cells assessed as accumulation at S phase at 10 uM after 48 hrs by propidium iodide-based flow cytometry2009Bioorganic & medicinal chemistry, Mar-15, Volume: 17, Issue:6
Effect of 3,4-ethylenedioxy-extension of thiophene core on the DNA/RNA binding properties and biological activity of bisbenzimidazole amidines.
AID536060Cytotoxicity against human HL-60(TB) cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID130327Tested for percentage increase in lifespan of drug-treated tumor-bearing animals when treated at optimal dose; NA=Inactive1994Journal of medicinal chemistry, Dec-09, Volume: 37, Issue:25
DNA-directed alkylating agents. 6. Synthesis and antitumor activity of DNA minor groove-targeted aniline mustard analogues of pibenzimol (Hoechst 33258)
AID133624Tested for the intraperitoneal optimal dose of 0.1 mL in tumor cells1994Journal of medicinal chemistry, Dec-09, Volume: 37, Issue:25
DNA-directed alkylating agents. 6. Synthesis and antitumor activity of DNA minor groove-targeted aniline mustard analogues of pibenzimol (Hoechst 33258)
AID569095Cytotoxicity against human MIAPaCa2 cells after 72 hrs by MTT assay2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis, DNA/RNA affinity and antitumour activity of new aromatic diamidines linked by 3,4-ethylenedioxythiophene.
AID1227433Inhibition of Escherichia coli DNA topoisomerase-1 using supercoiled pBAD-GFPuv plasmid DNA as substrate assessed as prevention of supercoiled DNA template from relaxation after 15 mins by agarose gel electrophoresis2014MedChemComm, Jun-01, Volume: 5, Issue:6
Selective Inhibition of Bacterial Topoisomerase I by alkynyl-bisbenzimidazoles.
AID1309046Antifungal activity against Candida albicans ATCC 10231 after 48 hrs by CLSI M27-A3 method2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Synthesis and investigation of novel benzimidazole derivatives as antifungal agents.
AID536182Cytotoxicity against human UO31 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID1309051Antifungal activity against Candida albicans ATCC MYA-1237 after 48 hrs by CLSI M27-A3 method2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Synthesis and investigation of novel benzimidazole derivatives as antifungal agents.
AID72882Thermal denaturation in alternating poly(dG-dC)-poly(dG-dC) homopolymer (GC)1993Journal of medicinal chemistry, Jun-11, Volume: 36, Issue:12
Structure, DNA minor groove binding, and base pair specificity of alkyl- and aryl-linked bis(amidinobenzimidazoles) and bis(amidinoindoles).
AID569120Induction of cell cycle arrest in human HeLa assessed as accumulation at S-phase at 5x10'-5 M after 72 hrs by FACS analysis (RVb = 62.2+/-4.4%)2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis, DNA/RNA affinity and antitumour activity of new aromatic diamidines linked by 3,4-ethylenedioxythiophene.
AID31892Thermal denaturation in alternating poly(dA-dT)poly(dA-dT) homopolymer (AT)1993Journal of medicinal chemistry, Jun-11, Volume: 36, Issue:12
Structure, DNA minor groove binding, and base pair specificity of alkyl- and aryl-linked bis(amidinobenzimidazoles) and bis(amidinoindoles).
AID536186Cytotoxicity against human MDA-MB-231 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID536176Cytotoxicity against human A498 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID536157Cytotoxicity against human SNB75 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID242163Inhibitory concentration required to displace DNA-bound ethidium bromide molecules bound to CA12 (5''-CGCGAATTCGCG)22004Bioorganic & medicinal chemistry letters, Oct-04, Volume: 14, Issue:19
New DNA binding ligands as a model of chromomycin A3.
AID536162Cytotoxicity against human MDA-MB-435 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID536177Cytotoxicity against human ACHN cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID689265Cytotoxicity against human U937 cells after 72 hrs by MTT assay2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
Newly synthesized bis-benzimidazole derivatives exerting anti-tumor activity through induction of apoptosis and autophagy.
AID536160Cytotoxicity against human MALME-3M cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID569122Induction of cell cycle arrest in human HeLa assessed as accumulation at G2/M-phase at 5x10'-5 M after 48 hrs by FACS analysis (RVb = 62.2+/-4.4%)2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis, DNA/RNA affinity and antitumour activity of new aromatic diamidines linked by 3,4-ethylenedioxythiophene.
AID536163Cytotoxicity against human SK-MEL-2 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID1227437Inhibition of Escherichia coli DNA gyrase using relaxed pBAD-GFPuv plasmid DNA as substrate at 1 to 50 uM after 30 mins by agarose gel electrophoresis2014MedChemComm, Jun-01, Volume: 5, Issue:6
Selective Inhibition of Bacterial Topoisomerase I by alkynyl-bisbenzimidazoles.
AID1227436Inhibition of human DNA topoisomerase-1 using supercoiled pBAD-GFPuv plasmid DNA as substrate assessed as prevention of supercoiled DNA template from relaxation at 50 uM after 30 mins by agarose gel electrophoresis relative to control2014MedChemComm, Jun-01, Volume: 5, Issue:6
Selective Inhibition of Bacterial Topoisomerase I by alkynyl-bisbenzimidazoles.
AID1309055Antifungal activity against Candida parapsilosis ATCC 22019 after 48 hrs by CLSI M27-A3 method2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Synthesis and investigation of novel benzimidazole derivatives as antifungal agents.
AID1227446Antibacterial activity against Escherichia coli K-12 after 24 hrs by microbroth dilution method2014MedChemComm, Jun-01, Volume: 5, Issue:6
Selective Inhibition of Bacterial Topoisomerase I by alkynyl-bisbenzimidazoles.
AID536151Cytotoxicity against human KM12 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID536156Cytotoxicity against human SNB19 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID1309050Antifungal activity against Candida albicans ATCC MYA-2310 after 48 hrs by CLSI M27-A3 method2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Synthesis and investigation of novel benzimidazole derivatives as antifungal agents.
AID1309047Antifungal activity against Candida albicans ATCC 64124 after 48 hrs by CLSI M27-A3 method2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Synthesis and investigation of novel benzimidazole derivatives as antifungal agents.
AID569093Cytotoxicity against human HeLa cells after 72 hrs by MTT assay2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis, DNA/RNA affinity and antitumour activity of new aromatic diamidines linked by 3,4-ethylenedioxythiophene.
AID536066Cytotoxicity against human EKVX cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID150501Concentration of the drug to inhibit wild type P388 murine leukemia cell growth in culture1994Journal of medicinal chemistry, Dec-09, Volume: 37, Issue:25
DNA-directed alkylating agents. 6. Synthesis and antitumor activity of DNA minor groove-targeted aniline mustard analogues of pibenzimol (Hoechst 33258)
AID3219Reaction Rate Parameter for 28-mer AATT hairpin2001Journal of medicinal chemistry, Aug-02, Volume: 44, Issue:16
Experimental precedent for the need to involve the primary hydration layer of DNA in lead drug design.
AID54423Denaturation temperature change on binding to AT to poly (dA)-poly(dT)1992Journal of medicinal chemistry, Feb-07, Volume: 35, Issue:3
Structure and DNA binding activity of analogues of 1,5-bis(4-amidinophenoxy)pentane (pentamidine)
AID569115Induction of cell cycle arrest in human HeLa assessed as accumulation at G0/G1-phase at 5x10'-5 M after 24 hrs by FACS analysis (RVb = 62.2+/-4.4%)2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis, DNA/RNA affinity and antitumour activity of new aromatic diamidines linked by 3,4-ethylenedioxythiophene.
AID212902Inhibition of human telomerase after assembly using recombinant hTR and hTERT at 50 uM2004Bioorganic & medicinal chemistry letters, Jul-05, Volume: 14, Issue:13
Nucleic acid-binding ligands identify new mechanisms to inhibit telomerase.
AID569091Cytotoxicity against human Caco2 cells after 72 hrs by MTT assay2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis, DNA/RNA affinity and antitumour activity of new aromatic diamidines linked by 3,4-ethylenedioxythiophene.
AID54272Intrinsic association constant for reversible binding of compounds to calf thymus DNA at 20 degree C1994Journal of medicinal chemistry, Dec-09, Volume: 37, Issue:25
DNA-directed alkylating agents. 6. Synthesis and antitumor activity of DNA minor groove-targeted aniline mustard analogues of pibenzimol (Hoechst 33258)
AID536154Cytotoxicity against human SF295 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID54984Thermal denaturation in sonicated calf thymus DNA (CT DNA)1993Journal of medicinal chemistry, Jun-11, Volume: 36, Issue:12
Structure, DNA minor groove binding, and base pair specificity of alkyl- and aryl-linked bis(amidinobenzimidazoles) and bis(amidinoindoles).
AID1227439Binding affinity to dA60.dT60 DNA (unknown origin) assessed as change in melting temperature at 10 uM by UV-Vis spectrophotometric analysis2014MedChemComm, Jun-01, Volume: 5, Issue:6
Selective Inhibition of Bacterial Topoisomerase I by alkynyl-bisbenzimidazoles.
AID202836Antitumor activity of compound for 96-h exposure in SKOV-3 human ovarian cell line2001Journal of medicinal chemistry, Jan-18, Volume: 44, Issue:2
A new class of symmetric bisbenzimidazole-based DNA minor groove-binding agents showing antitumor activity.
AID536056Inhibition of EGF-induced MEK1/2 activity in HEK293 cells assessed as phosphorylated ERK1/2 level at 10 uM after 1 hr by Western blotting relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID394432Cell cycle distribution in human HeLa cells assessed as accumulation at G0/G1 phase at 10 uM after 72 hrs by propidium iodide-based flow cytometry2009Bioorganic & medicinal chemistry, Mar-15, Volume: 17, Issue:6
Effect of 3,4-ethylenedioxy-extension of thiophene core on the DNA/RNA binding properties and biological activity of bisbenzimidazole amidines.
AID1309058Antifungal activity against Aspergillus terreus ATCC MYA3633 after 48 hrs by CLSI M38-A2 method2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Synthesis and investigation of novel benzimidazole derivatives as antifungal agents.
AID54424Denaturation temperature change on binding on GC to poly(dGC)-poly(dGC)1992Journal of medicinal chemistry, Feb-07, Volume: 35, Issue:3
Structure and DNA binding activity of analogues of 1,5-bis(4-amidinophenoxy)pentane (pentamidine)
AID536173Cytotoxicity against human NCI/ADR-RES cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID54427DNA binding activity as denaturation temperatures on AT to poly (dA)-poly(dT) normalized to ethidium bromide1992Journal of medicinal chemistry, Feb-07, Volume: 35, Issue:3
Structure and DNA binding activity of analogues of 1,5-bis(4-amidinophenoxy)pentane (pentamidine)
AID1309065Induction of ROS production in Candida albicans ATCC 10231 at 1 to 2 times MIC after 1 hr by DCFH-DA probe based fluorescence microscopy2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Synthesis and investigation of novel benzimidazole derivatives as antifungal agents.
AID536054Cytotoxicity against human MDA-N cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID1309061Fungicidal activity against Candida albicans ATCC 64124 assessed as reduction in fungal population at 2 times MIC after 24 to 48 hrs by time kill assay2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Synthesis and investigation of novel benzimidazole derivatives as antifungal agents.
AID536171Cytotoxicity against human OVCAR5 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID1309054Antifungal activity against Candida krusei ATCC 6258 after 48 hrs by CLSI M27-A3 method2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Synthesis and investigation of novel benzimidazole derivatives as antifungal agents.
AID212744Inhibition of telomerase before assembly using recombinant Tetraymena thermophilia TR and TERT at 50 uM2004Bioorganic & medicinal chemistry letters, Jul-05, Volume: 14, Issue:13
Nucleic acid-binding ligands identify new mechanisms to inhibit telomerase.
AID536067Cytotoxicity against human HOP62 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID569094Cytotoxicity against human AGS cells after 72 hrs by MTT assay2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis, DNA/RNA affinity and antitumour activity of new aromatic diamidines linked by 3,4-ethylenedioxythiophene.
AID569123Induction of cell cycle arrest in human HeLa assessed as accumulation at G2/M-phase at 5x10'-5 M after 72 hrs by FACS analysis (RVb = 62.2+/-4.4%)2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis, DNA/RNA affinity and antitumour activity of new aromatic diamidines linked by 3,4-ethylenedioxythiophene.
AID1309059Fungicidal activity against Candida albicans ATCC 64124 assessed as reduction in fungal population at MIC after 9 hrs by time kill assay2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Synthesis and investigation of novel benzimidazole derivatives as antifungal agents.
AID1227445Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by microbroth dilution method2014MedChemComm, Jun-01, Volume: 5, Issue:6
Selective Inhibition of Bacterial Topoisomerase I by alkynyl-bisbenzimidazoles.
AID536068Cytotoxicity against human HOP92 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID536175Cytotoxicity against human 786-0 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID536153Cytotoxicity against human SF268 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID569121Induction of cell cycle arrest in human HeLa assessed as accumulation at G2/M-phase at 5x10'-5 M after 24 hrs by FACS analysis (RVb = 62.2+/-4.4%)2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis, DNA/RNA affinity and antitumour activity of new aromatic diamidines linked by 3,4-ethylenedioxythiophene.
AID536170Cytotoxicity against human OVCAR4 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID536065Cytotoxicity against human A549 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID536188Cytotoxicity against human BT549 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID394438Cell cycle distribution in human HeLa cells assessed as accumulation at G2/M phase at 10 uM after 48 hrs by propidium iodide-based flow cytometry2009Bioorganic & medicinal chemistry, Mar-15, Volume: 17, Issue:6
Effect of 3,4-ethylenedioxy-extension of thiophene core on the DNA/RNA binding properties and biological activity of bisbenzimidazole amidines.
AID1309063Cytotoxicity against human BEAS2B cells assessed as reduction in cell survival after 6 hrs by resazurin assay2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Synthesis and investigation of novel benzimidazole derivatives as antifungal agents.
AID394442Cell cycle distribution in human HeLa cells assessed as accumulation at G2/M phase at 10 uM after 24 hrs by propidium iodide-based flow cytometry2009Bioorganic & medicinal chemistry, Mar-15, Volume: 17, Issue:6
Effect of 3,4-ethylenedioxy-extension of thiophene core on the DNA/RNA binding properties and biological activity of bisbenzimidazole amidines.
AID536064Cytotoxicity against human SR cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID536071Cytotoxicity against human NCI-H322M cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID394436Cell cycle distribution in human HeLa cells assessed as accumulation at S phase at 10 uM after 72 hrs by propidium iodide-based flow cytometry2009Bioorganic & medicinal chemistry, Mar-15, Volume: 17, Issue:6
Effect of 3,4-ethylenedioxy-extension of thiophene core on the DNA/RNA binding properties and biological activity of bisbenzimidazole amidines.
AID394440Cell cycle distribution in human HeLa cells assessed as accumulation at G2/M phase at 10 uM after 72 hrs by propidium iodide-based flow cytometry2009Bioorganic & medicinal chemistry, Mar-15, Volume: 17, Issue:6
Effect of 3,4-ethylenedioxy-extension of thiophene core on the DNA/RNA binding properties and biological activity of bisbenzimidazole amidines.
AID394419Antiproliferative activity against human MCF7 cells at 0.1 to 100 uM after 72 hrs by MTT assay2009Bioorganic & medicinal chemistry, Mar-15, Volume: 17, Issue:6
Effect of 3,4-ethylenedioxy-extension of thiophene core on the DNA/RNA binding properties and biological activity of bisbenzimidazole amidines.
AID536073Cytotoxicity against human NCI-H522 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID233938Ratio between poly-dAdT and poly-dGdC binding1993Journal of medicinal chemistry, Jun-11, Volume: 36, Issue:12
Structure, DNA minor groove binding, and base pair specificity of alkyl- and aryl-linked bis(amidinobenzimidazoles) and bis(amidinoindoles).
AID689263Cytotoxicity against human HeLa cells after 72 hrs by MTT assay2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
Newly synthesized bis-benzimidazole derivatives exerting anti-tumor activity through induction of apoptosis and autophagy.
AID536165Cytotoxicity against human SK-MEL-5 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID477017Displacement of ethidium bromide from calf thymus DNA assessed as decrease of fluorescence of bound ethidium bromide by fluorometric assay2010European journal of medicinal chemistry, Apr, Volume: 45, Issue:4
Synthesis, cytotoxicity and DNA-binding of novel bisnaphthalimidopropyl derivatives in breast cancer MDA-MB-231 cells.
AID536152Cytotoxicity against human SW620 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID1309049Antifungal activity against Candida albicans ATCC MYA-90819 after 48 hrs by CLSI M27-A3 method2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Synthesis and investigation of novel benzimidazole derivatives as antifungal agents.
AID536164Cytotoxicity against human SK-MEL-28 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID212903Inhibition of human telomerase before assembly using recombinant hTR and hTERT at 50 uM2004Bioorganic & medicinal chemistry letters, Jul-05, Volume: 14, Issue:13
Nucleic acid-binding ligands identify new mechanisms to inhibit telomerase.
AID1309064Cytotoxicity against human BEAS2B cells assessed as reduction in cell survival after 24 hrs by resazurin assay2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Synthesis and investigation of novel benzimidazole derivatives as antifungal agents.
AID536070Cytotoxicity against human NCI-H23 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID536063Cytotoxicity against human RPMI8266 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID304717Binding affinity to calf thymus DNA assessed as thermal stability in BPE buffer at 2 uM2007Journal of medicinal chemistry, Dec-27, Volume: 50, Issue:26
Amine-guanidine switch: a promising approach to improve DNA binding and antiproliferative activities.
AID1227434Inhibition of human DNA topoisomerase-1 using supercoiled pBAD-GFPuv plasmid DNA as substrate assessed as prevention of supercoiled DNA template from relaxation after 30 mins by agarose gel electrophoresis2014MedChemComm, Jun-01, Volume: 5, Issue:6
Selective Inhibition of Bacterial Topoisomerase I by alkynyl-bisbenzimidazoles.
AID1309060Fungistatic activity against Candida albicans ATCC 64124 assessed as reduction in fungal population at MIC upto 24 hrs by time kill assay2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Synthesis and investigation of novel benzimidazole derivatives as antifungal agents.
AID1227444Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by microbroth dilution method2014MedChemComm, Jun-01, Volume: 5, Issue:6
Selective Inhibition of Bacterial Topoisomerase I by alkynyl-bisbenzimidazoles.
AID536161Cytotoxicity against human M14 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID536189Cytotoxicity against human T47D cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID1227442Antibacterial activity against Staphylococcus aureus ATCC 29213 after 24 hrs by microbroth dilution method2014MedChemComm, Jun-01, Volume: 5, Issue:6
Selective Inhibition of Bacterial Topoisomerase I by alkynyl-bisbenzimidazoles.
AID212743Inhibition of telomerase after assembly using recombinant Tetraymena thermophilia TR and TERT at 50 uM2004Bioorganic & medicinal chemistry letters, Jul-05, Volume: 14, Issue:13
Nucleic acid-binding ligands identify new mechanisms to inhibit telomerase.
AID536187Cytotoxicity against human Hs 578T cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID7680Antitumor activity of compound for 96-h exposure in A2780cisR (acquired resistance to cisplatin) human ovarian cell line2001Journal of medicinal chemistry, Jan-18, Volume: 44, Issue:2
A new class of symmetric bisbenzimidazole-based DNA minor groove-binding agents showing antitumor activity.
AID47483Antitumor activity of compound for 96-h exposure in CH1 human ovarian cell line2001Journal of medicinal chemistry, Jan-18, Volume: 44, Issue:2
A new class of symmetric bisbenzimidazole-based DNA minor groove-binding agents showing antitumor activity.
AID569096Cytotoxicity against MDCK cells after 72 hrs by MTT assay2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis, DNA/RNA affinity and antitumour activity of new aromatic diamidines linked by 3,4-ethylenedioxythiophene.
AID569092Cytotoxicity against human Hep2 cells after 72 hrs by MTT assay2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis, DNA/RNA affinity and antitumour activity of new aromatic diamidines linked by 3,4-ethylenedioxythiophene.
AID242164Inhibitory concentration required to displace DNA-bound ethidium bromide molecules bound to CT12 (5''-CGTAGCGCTACG)22004Bioorganic & medicinal chemistry letters, Oct-04, Volume: 14, Issue:19
New DNA binding ligands as a model of chromomycin A3.
AID536062Cytotoxicity against human MOLT4 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID9844Association constant for binding to AATT duplex2001Journal of medicinal chemistry, Aug-02, Volume: 44, Issue:16
Experimental precedent for the need to involve the primary hydration layer of DNA in lead drug design.
AID31893Thermal denaturation in sonicated poly(dA)-poly(dT) homopolymer (AT)1993Journal of medicinal chemistry, Jun-11, Volume: 36, Issue:12
Structure, DNA minor groove binding, and base pair specificity of alkyl- and aryl-linked bis(amidinobenzimidazoles) and bis(amidinoindoles).
AID536055Activation of EGF-induced MEK1/2 activity in HEK293 cells assessed as phosphorylated ERK1/2 level at 10 uM after 1 hr by Western blotting relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID536159Cytotoxicity against human LOXIMVI cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID536183Cytotoxicity against human PC3 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID536174Cytotoxicity against human SKOV3 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID212741Inhibition of purified telomerase of Euplotes aediculatus at 50 uM2004Bioorganic & medicinal chemistry letters, Jul-05, Volume: 14, Issue:13
Nucleic acid-binding ligands identify new mechanisms to inhibit telomerase.
AID536150Cytotoxicity against human HT-29 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID1227447Antibacterial activity against Enterococcus faecalis ATCC 29212 after 24 hrs by microbroth dilution method2014MedChemComm, Jun-01, Volume: 5, Issue:6
Selective Inhibition of Bacterial Topoisomerase I by alkynyl-bisbenzimidazoles.
AID569090Cytotoxicity against human NCI-H358 cells after 72 hrs by MTT assay2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis, DNA/RNA affinity and antitumour activity of new aromatic diamidines linked by 3,4-ethylenedioxythiophene.
AID1309048Antifungal activity against Candida albicans ATCC MYA-2876 after 48 hrs by CLSI M27-A3 method2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Synthesis and investigation of novel benzimidazole derivatives as antifungal agents.
AID689264Cytotoxicity against human HL60 cells after 72 hrs by MTT assay2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
Newly synthesized bis-benzimidazole derivatives exerting anti-tumor activity through induction of apoptosis and autophagy.
AID536184Cytotoxicity against human DU145 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID469604Binding affinity to duplex DNA dA22.dT22 assessed as change in melting temperature at 3 uM by UV analysis at 260 nm2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
Triple recognition of B-DNA.
AID3220Reaction Rate Parameter for 28-mer AATT hairpin2001Journal of medicinal chemistry, Aug-02, Volume: 44, Issue:16
Experimental precedent for the need to involve the primary hydration layer of DNA in lead drug design.
AID1309056Antifungal activity against Aspergillus flavus ATCC MYA-3631 after 48 hrs by CLSI M38-A2 method2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Synthesis and investigation of novel benzimidazole derivatives as antifungal agents.
AID225935Association constant for binding to poly[d(A-T)].2001Journal of medicinal chemistry, Aug-02, Volume: 44, Issue:16
Experimental precedent for the need to involve the primary hydration layer of DNA in lead drug design.
AID536146Cytotoxicity against human COLO205 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID569118Induction of cell cycle arrest in human HeLa assessed as accumulation at S-phase at 5x10'-5 M after 24 hrs by FACS analysis (RVb = 62.2+/-4.4%)2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis, DNA/RNA affinity and antitumour activity of new aromatic diamidines linked by 3,4-ethylenedioxythiophene.
AID57051Compound was tested to determine equilibrium association constant on calf thymus DNA by fluorescence spectrometric analysis.1996Journal of medicinal chemistry, Nov-22, Volume: 39, Issue:24
[125I/127I]iodoHoechst 33342: synthesis, DNA binding, and biodistribution.
AID536057Activation of EGF-induced MEK5 activity in HEK293 cells assessed as phosphorylated ERK5 level at 10 uM after 1 hr by Western blotting relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID54426Denaturation temperature change on binding to calf thymus DNA1992Journal of medicinal chemistry, Feb-07, Volume: 35, Issue:3
Structure and DNA binding activity of analogues of 1,5-bis(4-amidinophenoxy)pentane (pentamidine)
AID536180Cytotoxicity against human SN12C cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID1309062Cytotoxicity against human A549 cells assessed as reduction in cell survival after 24 hrs by resazurin assay2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Synthesis and investigation of novel benzimidazole derivatives as antifungal agents.
AID569119Induction of cell cycle arrest in human HeLa assessed as accumulation at S-phase at 5x10'-5 M after 48 hrs by FACS analysis (RVb = 62.2+/-4.4%)2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis, DNA/RNA affinity and antitumour activity of new aromatic diamidines linked by 3,4-ethylenedioxythiophene.
AID282344Inhibition of human AICAR Tfase2004Journal of medicinal chemistry, Dec-30, Volume: 47, Issue:27
Virtual screening of human 5-aminoimidazole-4-carboxamide ribonucleotide transformylase against the NCI diversity set by use of AutoDock to identify novel nonfolate inhibitors.
AID536158Cytotoxicity against human U251 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID512633Binding affinity to human c-MYC Pu24I G-quadruplex structure assessed as stabilization of G-quadruplex by NMR spectroscopy2005Nature chemical biology, Aug, Volume: 1, Issue:3
Small-molecule interaction with a five-guanine-tract G-quadruplex structure from the human MYC promoter.
AID536167Cytotoxicity against human UACC62 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID536148Cytotoxicity against human HCT116 cells at 10 uM assessed as cell growth relative to control2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Structure-activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway.
AID1227435Inhibition of human DNA topoisomerase-2 using supercoiled pBAD-GFPuv plasmid DNA as substrate assessed as prevention of supercoiled DNA template from relaxation after 30 mins by agarose gel electrophoresis2014MedChemComm, Jun-01, Volume: 5, Issue:6
Selective Inhibition of Bacterial Topoisomerase I by alkynyl-bisbenzimidazoles.
AID3217Association constant for binding to AATT 28-mer AATT hairpin2001Journal of medicinal chemistry, Aug-02, Volume: 44, Issue:16
Experimental precedent for the need to involve the primary hydration layer of DNA in lead drug design.
AID304718Binding affinity to calf thymus dodecamer DNA assessed as thermal stability in cacodylate buffer at 12 uM2007Journal of medicinal chemistry, Dec-27, Volume: 50, Issue:26
Amine-guanidine switch: a promising approach to improve DNA binding and antiproliferative activities.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (1,156)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990283 (24.48)18.7374
1990's346 (29.93)18.2507
2000's336 (29.07)29.6817
2010's172 (14.88)24.3611
2020's19 (1.64)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 14.96

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index14.96 (24.57)
Research Supply Index7.11 (2.92)
Research Growth Index4.44 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (14.96)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (0.16%)5.53%
Reviews21 (1.72%)6.00%
Case Studies1 (0.08%)4.05%
Observational0 (0.00%)0.25%
Other1,194 (98.03%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]